These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1800627)

  • 21. Clinical and bacteriological evaluation of Branhamella catarrhalis in respiratory infections.
    Saito A; Yamaguchi K; Shigeno Y; Kohno S; Shigeno H; Kusano N; Dotsu Y; Hara K
    Drugs; 1986; 31 Suppl 3():87-92. PubMed ID: 3488201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and microbiological features of Branhamella catarrhalis bronchopulmonary infections.
    Slevin NJ; Aitken J; Thornley PE
    Lancet; 1984 Apr; 1(8380):782-3. PubMed ID: 6143094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.
    McGregor K; Chang BJ; Mee BJ; Riley TV
    Eur J Clin Microbiol Infect Dis; 1998 Apr; 17(4):219-34. PubMed ID: 9707304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of Moraxella (Branhamella) catarrhalis as a respiratory pathogen in children.
    Korppi M; Katila ML; Jääskeläinen J; Leinonen M
    Acta Paediatr; 1992 Dec; 81(12):993-6. PubMed ID: 1290865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Branhamella catarrhalis respiratory infections.
    Barreiro B; Esteban L; Prats E; Verdaguer E; Dorca J; Manresa F
    Eur Respir J; 1992 Jun; 5(6):675-9. PubMed ID: 1628725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Moraxella (Branhamella) catarrhalis: clinical, microbiological and immunological features in lower respiratory tract infections.
    Christensen JJ
    APMIS Suppl; 1999; 88():1-36. PubMed ID: 10189833
    [No Abstract]   [Full Text] [Related]  

  • 27. [Moraxella (Branhamella) catarrhalis: its isolation in the respiratory secretions of adult patients].
    Ferrer Marcellés A; Martínez Ojeda E; Falcó Ferrer V; de la Torre Tejedor E; González Fuente T
    An Med Interna; 1997 Nov; 14(11):554-8. PubMed ID: 9445580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Respiratory tract carrier rates of Moraxella (Branhamella) catarrhalis in adults and children and interpretation of the isolation of M. catarrhalis from sputum.
    Vaneechoutte M; Verschraegen G; Claeys G; Weise B; Van den Abeele AM
    J Clin Microbiol; 1990 Dec; 28(12):2674-80. PubMed ID: 2126266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of isolation of Moraxella catarrhalis in routine cultures from the respiratory tract in adults: antibody response studied in a whole cell EIA.
    Jönsson I; Holme T; Krook A
    Scand J Infect Dis; 1994; 26(5):553-8. PubMed ID: 7855552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Branhamella catarrhalis as a lower respiratory tract pathogen in patients with chronic lung disease.
    Nicotra B; Rivera M; Luman JI; Wallace RJ
    Arch Intern Med; 1986 May; 146(5):890-3. PubMed ID: 3963981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Branhamella catarrhalis as a disease pathogen].
    Simon C
    Fortschr Med; 1991 Jul; 109(22):447-8. PubMed ID: 1937324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Moraxella (Branhamella) catarrhalis adherence to human bronchial and oropharyngeal cells: the role of adherence in lower respiratory tract infections.
    Rikitomi N; Ahmed K; Nagatake T
    Microbiol Immunol; 1997; 41(6):487-94. PubMed ID: 9251060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Branhamella catarrhalis respiratory infections in The Netherlands.
    Maesen FP; Davies BI
    Drugs; 1986; 31 Suppl 3():83-6. PubMed ID: 3732084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical, diagnostic and therapeutic aspects of Moraxella catarrhalis infections].
    Bourgeois F; Lambert-Zechovsky N; Bingen E
    Pathol Biol (Paris); 1993 Jun; 41(6):555-61. PubMed ID: 8247636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Respiratory tract infection: epidemiology and surveillance.
    Jacobs MR
    J Chemother; 1997 May; 9 Suppl 3():10-7. PubMed ID: 9248976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Respiratory tract infections caused by Branhamella catarrhalis in outpatients with pneumoconiosis].
    Ide M; Takasugi M; Yoshida S; Mori K; Mochinaga S; Yoshida T; Matsumoto K
    Kansenshogaku Zasshi; 1989 Apr; 63(4):363-8. PubMed ID: 2506294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Moraxella catarrhalis in chronic and relapsing respiratory tract infections in children].
    Volkov IK; Katosova LK; Shcherbakova NIu; Kliukina LP
    Antibiot Khimioter; 2004; 49(8-9):43-7. PubMed ID: 15727145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA restriction patterns produced by pulsed-field gel electrophoresis in Moraxella catarrhalis isolated from different geographical areas.
    Martinez G; Ahmed K; Zheng CH; Watanabe K; Oishi K; Nagatake T
    Epidemiol Infect; 1999 Jun; 122(3):417-22. PubMed ID: 10459644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of fimbriae and host response in Branhamella catarrhalis respiratory infections.
    Ahmed K; Masaki H; Dai TC; Ichinose A; Utsunomiya Y; Tao M; Nagatake T; Matsumoto K
    Microbiol Immunol; 1994; 38(10):767-71. PubMed ID: 7869954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Respiratory tract infections due to Branhamella catarrhalis: epidemiological data from Western Australia.
    DiGiovanni C; Riley TV; Hoyne GF; Yeo R; Cooksey P
    Epidemiol Infect; 1987 Oct; 99(2):445-53. PubMed ID: 3119360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.